Clinical Trials
16 trialsNCT07562763 2026-05-01
HCC
Anhui Provincial Hospital
Completed
NCT02771405 2026-04-13
FRI-STC
National Hepatology & Tropical Medicine Research Institute
Phase 3 Completed
NCT01022476 2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2 Completed
NCT00116454 2026-04-03
Lipiocis
ANRS, Emerging Infectious Diseases
Phase 3 Completed
NCT07349576 2026-01-20
Precision Dietary Intervention Improves Postoperative Energy Intake, Nutritional Status, and Recovery in Patients Undergoing Hepatectomy for Liver Cancer: A Randomized Controlled Trial
Anhui Provincial Hospital
Phase NA Completed
NCT03071458 2025-12-10
MUTHEC
Institut National de la Santé Et de la Recherche Médicale, France
Completed
NCT05370001 2023-02-13
Endotracheal Tube Size Effect on the Carbon Dioxide Washout During Jet Ventilation
Region Stockholm
Phase NA Completed
NCT04721470 2021-01-22
Combined Therapy for Hepatocellular Carcinoma >3-<5 cm
Zagazig University
Phase NA Completed
NCT04687280 2020-12-29
CHIC MultiA
University Hospital, Angers
Completed
NCT04652947 2020-12-03
MR Quality + Diagnostic Performance for CHC Diagnosis - Gadoxetic Acid, Gadoteric Acid and P03277 Comparison
University Hospital, Angers
Completed
NCT04568330 2020-09-29
Prevention of Hand-foot Skin Reaction
Taipei Veterans General Hospital, Taiwan
Phase NA Completed
NCT02395523 2020-07-07
Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular Carcinoma
National Cancer Center, Korea
Phase NA Completed
NCT01643824 2018-08-23
Hypofractionated Proton Beam Radiotherapy for Hepatocellular Carcinoma
National Cancer Center, Korea
Phase NA Completed
NCT00919009 2012-05-30
Combination of Transcatheter Arterial Chemoembolization (TACE) and Sorafenib for Patients With Unresectable Hepatocellular Carcinoma (HCC)
National Cancer Center, Korea
Phase 2 Completed
NCT00662246 2012-04-03
Dose Escalation Study Using Proton Beam Radiotherapy for Hepatocellular Carcinoma
National Cancer Center, Korea
Phase 1 Completed
NCT01018381 2009-11-23
Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection
The 108 Military Central Hospital
Phase NA Completed